期刊文献+

Observation on the quality of life before and after the injection of antiangiogenic drug in the vitreous cavity of patients with wet age-related macular degeneration 被引量:1

Observation on the quality of life before and after the injection of antiangiogenic drug in the vitreous cavity of patients with wet age-related macular degeneration
下载PDF
导出
摘要 Objective: To explore the vision-related quality of life ( VRQL) before and after the injection of antiangiogenic drug into the vitreous cavity of patients with wet age-related macular degeneration ( AMD) . Methods: The 2000 edition of the Visual Functioning Questionnaire 25 that was issued by the Na-tional Eye Institute was applied, and the VRQL evaluation was conducted on the initially diagnosed patients with wet-AMD before and after the injection of ranibizumab into the vitreous cavity. Results: Among the wet-AMD patients, patients with better distance visual acuity before the in-travitreal injection had a lower VFQ-25 score. After the vitreous cavity injection, the VFQ-25 questionnaire score was related to patient care and education from the doctors and nurses; specific-ally, the better the nursing, the higher the score. Conclusions: Before the vitreous cavity injection, the degree of distance visual acuity is an im-portant factor affecting the VRQL of wet-AMD patients. In addition, patient care and education from the doctors and nurses toward patients during the pre-, intra-and post-operation of the intrav-itreal injection are also important factors affecting the VRQL. Objective: To explore the vision-related quality of life ( VRQL) before and after the injection of antiangiogenic drug into the vitreous cavity of patients with wet age-related macular degeneration ( AMD) . Methods: The 2000 edition of the Visual Functioning Questionnaire 25 that was issued by the Na-tional Eye Institute was applied, and the VRQL evaluation was conducted on the initially diagnosed patients with wet-AMD before and after the injection of ranibizumab into the vitreous cavity. Results: Among the wet-AMD patients, patients with better distance visual acuity before the in-travitreal injection had a lower VFQ-25 score. After the vitreous cavity injection, the VFQ-25 questionnaire score was related to patient care and education from the doctors and nurses; specific-ally, the better the nursing, the higher the score. Conclusions: Before the vitreous cavity injection, the degree of distance visual acuity is an im-portant factor affecting the VRQL of wet-AMD patients. In addition, patient care and education from the doctors and nurses toward patients during the pre-, intra-and post-operation of the intrav-itreal injection are also important factors affecting the VRQL.
出处 《Chinese Nursing Research》 CAS 2015年第1期35-39,共5页 护理研究(英文版)
基金 supported by National Natural Science Fund Project(No.81470029) Science and Technology Commission of Shanghai Natural fund Project(No.11JC410602)
关键词 Age-related macular degeneration Intravitreal injection Quality of life Age-related macular degeneration Intravitreal injection Quality of life
  • 相关文献

参考文献16

  • 1Nowak-Sliwinska P,van den Bergh H,Sickenberg M,Koh AH.Photodynamic therapy for polypoidal choroidal vasculopathy. Progress in retinal and eye research . 2013
  • 2Figurska Ma?gorzata,Wierzbowska Joanna,Robaszkiewicz Jacek.Severe decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy. Medical science monitor : international medical journal of experimental and clinical research . 2011
  • 3Kati Kinnunen,Seppo Yl?,-Herttuala.??Vascular endothelial growth factors in retinal and choroidal neovascular diseases(J)Annals of Medicine . 2012 (1)
  • 4Laurence S Lim,Paul Mitchell,Johanna M Seddon,Frank G Holz,Tien Y Wong.??Age-related macular degeneration(J)The Lancet . 2012 (9827)
  • 5Luis J. Haddock,David J. Ramsey,Lucy H. Young.??Complications of Subspecialty Ophthalmic Care: Endophthalmitis after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Medications(J)Seminars in Ophthalmology . 2014 (5-6)
  • 6Renske G. Wieberdink,Lintje Ho,M. Kamran Ikram,Peter J. Koudstaal,Albert Hofman,Paulus T.V.M. de Jong,Johannes R. Vingerling,Monique M.B. Breteler.??Age-Related Macular Degeneration and the Risk of Stroke: The Rotterdam Study(J)Stroke . 2011 (8)
  • 7邹海东,柏林,刘海芸,张皙.老年性黄斑变性对生存质量的影响[J].中华眼底病杂志,2004,20(5):303-306. 被引量:25
  • 8Robert P. Finger,Robyn H. Guymer,Mark C. Gillies,Jill E. Keeffe.??The Impact of Anti-Vegf Treatment on Quality of Life in Neovascular Age-Related Macular Degeneration(J)Ophthalmology . 2013
  • 9Francesco Semeraro,Francesco Morescalchi,Sarah Duse,Elena Gambicorti,Mario R Romano,Ciro Costagliola.??Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview(J)Expert Opinion on Drug Safety . 2014 (6)
  • 10Paul Mitchell.??A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab(J)Current Medical Research & Opinion . 2011 (7)

二级参考文献11

  • 1VanNewkirk MR, Weih L, McCarty CA, et al. Visual impairment and eye diseases in elderly institutionalized Australians. Ophthalmology, 2000,107:2203-2208.
  • 2Munoz B, West SH, Rubin CS, et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury eye evaluation study. Arch Ophthalmol, 2000,118:819-825.
  • 3Riusala A, Sarna S, Immonen I. Visual function index (VF-14) in exudative age-related macular degeneration of long duration. Am J Ophthalmol, 2003,135:206-212.
  • 4Mackenzie PJ, Chang TS, Scott IU, et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 2002,109:720-729.
  • 5Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol, 1999,128:45-53.
  • 6Clemons TE, Chew EY, Bressler SB, et al. National Eye Institute Visual Function Questionnaire in the age-related eye disease study(AREDS). Arch Ophthalmol, 2003,121:211-217.
  • 7Wolffsohn JS, Cochrane AL. Implementation methods for vision related quality of life questionnaires. Br J Ophthalmol, 2000,84:1035-1040.
  • 8Wolffsohn JS, Cochrane AL. Design of the low vision quality-of-life questionnaire(LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol, 2000,130:793-802.
  • 9Holladay JT, Prager TC. Mean visual acuity (letter). Am J Ophthalmol, 1991,111:372-374.
  • 10Monestam E, Wachtmeister L. Dissatisfaction with cataract surgery in relation to visual results in a population-based study in Sweden. J Cataract Refract Surg, 1999,25:1127-1134.

共引文献25

同被引文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部